0001567619-19-001864.txt : 20190129 0001567619-19-001864.hdr.sgml : 20190129 20190129185832 ACCESSION NUMBER: 0001567619-19-001864 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190125 FILED AS OF DATE: 20190129 DATE AS OF CHANGE: 20190129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROWLAND LLOYD A CENTRAL INDEX KEY: 0001236395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 19549943 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273521219 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2019-01-25 0 0001501989 CytomX Therapeutics, Inc. CTMX 0001236395 ROWLAND LLOYD A C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 General Counsel Stock Option (right to buy) 16.85 2019-01-25 4 A 0 54900 0.00 A 2029-01-24 Common Stock 54900 54900 D 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. /s/ Debanjan Ray, as Attorney-in-Fact for Lloyd Rowland 2019-01-29